Publication | Open Access
A novel ultrasensitive assay for plasma p‐tau217: Performance in individuals with subjective cognitive decline and early Alzheimer's disease
81
Citations
28
References
2023
Year
UGOT p-tau217 can be an easily accessible and efficient way to screen and monitor patients with suspected AD pathophysiology, even in the early stages of the continuum.
| Year | Citations | |
|---|---|---|
Page 1
Page 1